ACT CAPITAL MANAGEMENT, LLC Holdings

ACT CAPITAL MANAGEMENT, LLC is an investment fund managing more than 72.46M US dollars. The largest holdings include STAAR Surgical Company, Exxon Mobil and Devon Energy. In Q3 2022 the fund bought assets of total value of 15.31M US dollars and sold assets of total value of 14.8M US dollars.

$72.45M

portfolio value

+0.41%

quarter

-62.35%

1 year

ACT CAPITAL MANAGEMENT, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q3 2021	35013000	37837000
Q4 2021	10998000	49046000
Q1 2022	15173000	52290000
Q2 2022	16070000	34645000
Q3 2022	15309000	14796000

ACT CAPITAL MANAGEMENT, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Medical Instruments & Supplies STAAR Surgical Company Portfolio share: 21.69% Portfolio value: 15.71M Avg. open price: $152.5 Current price: $63.32 P/L: -58.48% Sold -2.66% shares Q3 2022	share	21.69%	15.71M	$152.5	$63.32	-58.48%	Sold -2.66% shares Q3 2022
Oil & Gas Integrated Exxon Mobil Corporation Portfolio share: 9.83% Portfolio value: 7.12M Avg. open price: $85.64 Current price: $109.86 P/L: +28.28% Bought +43.41% shares Q3 2022	share	9.83%	7.12M	$85.64	$109.86	+28.28%	Bought +43.41% shares Q3 2022
Oil & Gas E&P Devon Energy Corporation Portfolio share: 6.85% Portfolio value: 4.96M Avg. open price: $59.13 Current price: $68.46 P/L: +15.78% Bought +85.39% shares Q2 2022	share	6.85%	4.96M	$59.13	$68.46	+15.78%	Bought +85.39% shares Q2 2022
Biotechnology Krystal Biotech, Inc. Portfolio share: 5.61% Portfolio value: 4.06M Avg. open price: $60.49 Current price: $77.5 P/L: +28.13% Sold -1.19% shares Q3 2022	share	5.61%	4.06M	$60.49	$77.5	+28.13%	Sold -1.19% shares Q3 2022
Biotechnology Arrowhead Pharmaceuticals, Inc. Portfolio share: 5.04% Portfolio value: 3.65M Avg. open price: $62.43 Current price: $33.93 P/L: -45.65% Sold -18.15% shares Q3 2022	share	5.04%	3.65M	$62.43	$33.93	-45.65%	Sold -18.15% shares Q3 2022
Biotechnology Axsome Therapeutics, Inc. Portfolio share: 4.50% Portfolio value: 3.25M Avg. open price: N/A Current price: $76.9 P/L: N/A N/A Q3 2022	share	4.50%	3.25M	N/A	$76.9	N/A	N/A Q3 2022
Oil & Gas Integrated Chevron Corporation Portfolio share: 4.46% Portfolio value: 3.23M Avg. open price: $159.98 Current price: $181.03 P/L: +13.16% Bought +15.38% shares Q3 2022	share	4.46%	3.23M	$159.98	$181.03	+13.16%	Bought +15.38% shares Q3 2022
Communication Equipment ADTRAN Holdings, Inc. Portfolio share: 4.05% Portfolio value: 2.93M Avg. open price: $18.45 Current price: $20.87 P/L: +13.12% N/A Q3 2022	share	4.05%	2.93M	$18.45	$20.87	+13.12%	N/A Q3 2022
Medical Devices enVVeno Medical Corporation Portfolio share: 3.48% Portfolio value: 2.52M Avg. open price: $6.33 Current price: $5.93 P/L: -6.34% Bought +52.84% shares Q1 2022	share	3.48%	2.52M	$6.33	$5.93	-6.34%	Bought +52.84% shares Q1 2022
Biotechnology Clearside Biomedical, Inc. Portfolio share: 3.43% Portfolio value: 2.48M Avg. open price: $5.73 Current price: $1.2 P/L: -79.06% Sold -3.96% shares Q3 2022	share	3.43%	2.48M	$5.73	$1.2	-79.06%	Sold -3.96% shares Q3 2022
Oil & Gas E&P Laredo Petroleum, Inc. Portfolio share: 2.94% Portfolio value: 2.13M Avg. open price: $68.94 Current price: $61.54 P/L: -10.73% Bought +164.84% shares Q3 2022	share	2.94%	2.13M	$68.94	$61.54	-10.73%	Bought +164.84% shares Q3 2022
Biotechnology Arcturus Therapeutics Holdings Inc. Portfolio share: 2.46% Portfolio value: 1.78M Avg. open price: $47.78 Current price: $19.1 P/L: -60.03% Sold -46.87% shares Q3 2022	share	2.46%	1.78M	$47.78	$19.1	-60.03%	Sold -46.87% shares Q3 2022
Biotechnology Eiger BioPharmaceuticals, Inc. Portfolio share: 2.44% Portfolio value: 1.77M Avg. open price: $5.21 Current price: $4.53 P/L: -13.05% Sold -6.00% shares Q3 2022	share	2.44%	1.77M	$5.21	$4.53	-13.05%	Sold -6.00% shares Q3 2022
Biotechnology Verona Pharma plc Portfolio share: 2.02% Portfolio value: 1.46M Avg. open price: N/A Current price: $13.94 P/L: N/A N/A Q3 2022	share	2.02%	1.46M	N/A	$13.94	N/A	N/A Q3 2022
Oil & Gas Midstream Energy Transfer LP Portfolio share: 1.95% Portfolio value: 1.41M Avg. open price: N/A Current price: $12.53 P/L: N/A N/A Q2 2022	share	1.95%	1.41M	N/A	$12.53	N/A	N/A Q2 2022
Oil & Gas E&P Diamondback Energy, Inc. Portfolio share: 1.75% Portfolio value: 1.26M Avg. open price: $121.15 Current price: $145.46 P/L: +20.07% Bought +162.50% shares Q3 2022	share	1.75%	1.26M	$121.15	$145.46	+20.07%	Bought +162.50% shares Q3 2022
Biotechnology Myovant Sciences Ltd. Portfolio share: 1.49% Portfolio value: 1.07M Avg. open price: N/A Current price: $26.91 P/L: N/A Sold -7.69% shares Q3 2022	share	1.49%	1.07M	N/A	$26.91	N/A	Sold -7.69% shares Q3 2022
Biotechnology INmune Bio, Inc. Portfolio share: 1.29% Portfolio value: 937K Avg. open price: N/A Current price: $6.91 P/L: N/A Sold -5.86% shares Q3 2022	share	1.29%	937K	N/A	$6.91	N/A	Sold -5.86% shares Q3 2022
Biotechnology Inhibikase Therapeutics, Inc. Portfolio share: 1.18% Portfolio value: 853K Avg. open price: $2.5 Current price: $0.57 P/L: -77.06% Sold -12.91% shares Q2 2022	share	1.18%	853K	$2.5	$0.57	-77.06%	Sold -12.91% shares Q2 2022
Entertainment Roku, Inc. Portfolio share: 1.05% Portfolio value: 761K Avg. open price: $82.14 Current price: $60.73 P/L: -26.07% Bought +141.07% shares Q3 2022	share	1.05%	761K	$82.14	$60.73	-26.07%	Bought +141.07% shares Q3 2022
Biotechnology Affimed N.V. Portfolio share: 0.88% Portfolio value: 636K Avg. open price: $6.18 Current price: $2.09 P/L: -66.18% Bought +9.78% shares Q4 2021	share	0.88%	636K	$6.18	$2.09	-66.18%	Bought +9.78% shares Q4 2021
Communication Equipment Cambium Networks Corporation Portfolio share: 0.80% Portfolio value: 582K Avg. open price: N/A Current price: $23.06 P/L: N/A N/A Q3 2022	share	0.80%	582K	N/A	$23.06	N/A	N/A Q3 2022
Medical Devices TransMedics Group, Inc. Portfolio share: 0.72% Portfolio value: 522K Avg. open price: N/A Current price: $64.29 P/L: N/A N/A Q3 2022	share	0.72%	522K	N/A	$64.29	N/A	N/A Q3 2022
Computer Hardware Stratasys Ltd. Portfolio share: 0.70% Portfolio value: 504K Avg. open price: $22.84 Current price: $13.84 P/L: -39.40% Sold -30.00% shares Q3 2022	share	0.70%	504K	$22.84	$13.84	-39.40%	Sold -30.00% shares Q3 2022
Biotechnology Champions Oncology, Inc. Portfolio share: 0.65% Portfolio value: 469K Avg. open price: $10.26 Current price: $6.95 P/L: -32.25% Bought +6.84% shares Q4 2021	share	0.65%	469K	$10.26	$6.95	-32.25%	Bought +6.84% shares Q4 2021
Medical Devices iCAD, Inc. Portfolio share: 0.59% Portfolio value: 431K Avg. open price: $10.91 Current price: $1.82 P/L: -83.32% Sold -30.39% shares Q2 2022	share	0.59%	431K	$10.91	$1.82	-83.32%	Sold -30.39% shares Q2 2022
Software—Application Unity Software Inc. Portfolio share: 0.55% Portfolio value: 398K Avg. open price: N/A Current price: $40.94 P/L: N/A Sold -52.47% shares Q3 2022	share	0.55%	398K	N/A	$40.94	N/A	Sold -52.47% shares Q3 2022
Oil & Gas E&P Vista Energy, S.A.B. de C.V. Portfolio share: 0.54% Portfolio value: 391K Avg. open price: N/A Current price: $13.65 P/L: N/A N/A Q2 2022	share	0.54%	391K	N/A	$13.65	N/A	N/A Q2 2022
Oil & Gas E&P Denbury Inc. Portfolio share: 0.48% Portfolio value: 345K Avg. open price: N/A Current price: $87.93 P/L: N/A N/A Q3 2022	share	0.48%	345K	N/A	$87.93	N/A	N/A Q3 2022
Software—Application Zeta Global Holdings Corp. Portfolio share: 0.47% Portfolio value: 340K Avg. open price: N/A Current price: $8.78 P/L: N/A Sold -28.97% shares Q3 2022	share	0.47%	340K	N/A	$8.78	N/A	Sold -28.97% shares Q3 2022
Software—Infrastructure Block, Inc. Portfolio share: 0.46% Portfolio value: 330K Avg. open price: N/A Current price: $68.18 P/L: N/A N/A Q3 2022	share	0.46%	330K	N/A	$68.18	N/A	N/A Q3 2022
Broadcasting fuboTV Inc. Portfolio share: 0.39% Portfolio value: 284K Avg. open price: N/A Current price: $2.83 P/L: N/A Sold -27.27% shares Q3 2022	share	0.39%	284K	N/A	$2.83	N/A	Sold -27.27% shares Q3 2022
Telecom Services QualTek Services Inc. Portfolio share: 0.38% Portfolio value: 278K Avg. open price: N/A Current price: $0.8 P/L: N/A Sold -53.83% shares Q3 2022	share	0.38%	278K	N/A	$0.8	N/A	Sold -53.83% shares Q3 2022
Biotechnology OncoCyte Corporation Portfolio share: 0.33% Portfolio value: 241K Avg. open price: N/A Current price: $0.5 P/L: N/A N/A Q2 2021	share	0.33%	241K	N/A	$0.5	N/A	N/A Q2 2021
Oil & Gas E&P Chesapeake Energy Corporation Portfolio share: 0.33% Portfolio value: 236K Avg. open price: N/A Current price: $101.75 P/L: N/A N/A Q3 2022	share	0.33%	236K	N/A	$101.75	N/A	N/A Q3 2022
Software—Application Rumble Inc. Portfolio share: 0.32% Portfolio value: 234K Avg. open price: N/A Current price: $8.76 P/L: N/A N/A Q3 2022	share	0.32%	234K	N/A	$8.76	N/A	N/A Q3 2022
Biotechnology Leap Therapeutics, Inc. Portfolio share: 0.32% Portfolio value: 233K Avg. open price: $3.39 Current price: $0.57 P/L: -83.07% Bought +17.78% shares Q1 2022	share	0.32%	233K	$3.39	$0.57	-83.07%	Bought +17.78% shares Q1 2022
Biotechnology Oncternal Therapeutics, Inc. Portfolio share: 0.26% Portfolio value: 187K Avg. open price: N/A Current price: $0.93 P/L: N/A Sold -6.67% shares Q2 2022	share	0.26%	187K	N/A	$0.93	N/A	Sold -6.67% shares Q2 2022
Biotechnology Cardiff Oncology, Inc. Portfolio share: 0.26% Portfolio value: 186K Avg. open price: $6.21 Current price: $1.57 P/L: -74.72% Bought +17.66% shares Q1 2022	share	0.26%	186K	$6.21	$1.57	-74.72%	Bought +17.66% shares Q1 2022
Biotechnology Surface Oncology, Inc. Portfolio share: 0.24% Portfolio value: 177K Avg. open price: N/A Current price: $0.98 P/L: N/A N/A Q2 2021	share	0.24%	177K	N/A	$0.98	N/A	N/A Q2 2021
Software—Application Snowflake Inc. Portfolio share: 0.23% Portfolio value: 170K Avg. open price: N/A Current price: $149.74 P/L: N/A N/A Q3 2022	share	0.23%	170K	N/A	$149.74	N/A	N/A Q3 2022
Diagnostics & Research Aspira Women's Health Inc. Portfolio share: 0.21% Portfolio value: 155K Avg. open price: N/A Current price: $0.37 P/L: N/A Sold -35.43% shares Q3 2022	share	0.21%	155K	N/A	$0.37	N/A	Sold -35.43% shares Q3 2022
Software—Infrastructure DigitalOcean Holdings, Inc. Portfolio share: 0.20% Portfolio value: 145K Avg. open price: $82.38 Current price: $30.84 P/L: -62.56% Sold -60.00% shares Q3 2022	share	0.20%	145K	$82.38	$30.84	-62.56%	Sold -60.00% shares Q3 2022
Biotechnology Cassava Sciences, Inc. Portfolio share: 0.20% Portfolio value: 142K Avg. open price: N/A Current price: $35.83 P/L: N/A N/A Q3 2022	share	0.20%	142K	N/A	$35.83	N/A	N/A Q3 2022
Biotechnology Marker Therapeutics, Inc. Portfolio share: 0.18% Portfolio value: 131K Avg. open price: $2.79 Current price: $0.3 P/L: -89.29% Sold -19.34% shares Q4 2021	share	0.18%	131K	$2.79	$0.3	-89.29%	Sold -19.34% shares Q4 2021
Drug Manufacturers—Specialty & Generic Neoleukin Therapeutics, Inc. Portfolio share: 0.18% Portfolio value: 127K Avg. open price: N/A Current price: $0.47 P/L: N/A Sold -6.35% shares Q1 2022	share	0.18%	127K	N/A	$0.47	N/A	Sold -6.35% shares Q1 2022
Biotechnology Medicenna Therapeutics Corp. Portfolio share: 0.17% Portfolio value: 124K Avg. open price: N/A Current price: $0.55 P/L: N/A Sold -2.25% shares Q2 2022	share	0.17%	124K	N/A	$0.55	N/A	Sold -2.25% shares Q2 2022
Biotechnology Gritstone bio, Inc. Portfolio share: 0.17% Portfolio value: 122K Avg. open price: $13 Current price: $2.93 P/L: -77.46% Bought +18.75% shares Q1 2022	share	0.17%	122K	$13	$2.93	-77.46%	Bought +18.75% shares Q1 2022
Biotechnology Adaptimmune Therapeutics plc Portfolio share: 0.13% Portfolio value: 97K Avg. open price: N/A Current price: $2.06 P/L: N/A N/A Q3 2021	share	0.13%	97K	N/A	$2.06	N/A	N/A Q3 2021
Aerospace & Defense Draganfly Inc. Portfolio share: 0.13% Portfolio value: 95K Avg. open price: $3.35 Current price: $0.89 P/L: -73.36% Sold -30.77% shares Q1 2022	share	0.13%	95K	$3.35	$0.89	-73.36%	Sold -30.77% shares Q1 2022
CBDMD INC Portfolio share: 0.11% Portfolio value: 77K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022	share	0.11%	77K	N/A	N/A	N/A	N/A Q2 2022
Biotechnology Cellectar Biosciences, Inc. Portfolio share: 0.10% Portfolio value: 73K Avg. open price: N/A Current price: $1.87 P/L: N/A N/A Q3 2022	share	0.10%	73K	N/A	$1.87	N/A	N/A Q3 2022
Biotechnology Enlivex Therapeutics Ltd. Portfolio share: 0.09% Portfolio value: 64K Avg. open price: N/A Current price: $4.46 P/L: N/A Sold -40.00% shares Q2 2022	share	0.09%	64K	N/A	$4.46	N/A	Sold -40.00% shares Q2 2022
Oil & Gas Equipment & Services Superior Drilling Products, Inc. Portfolio share: 0.07% Portfolio value: 54K Avg. open price: N/A Current price: $0.83 P/L: N/A Sold -25.58% shares Q1 2022	share	0.07%	54K	N/A	$0.83	N/A	Sold -25.58% shares Q1 2022
Medical Devices Cytosorbents Corporation Portfolio share: 0.07% Portfolio value: 48K Avg. open price: N/A Current price: $1.42 P/L: N/A N/A Q2 2021	share	0.07%	48K	N/A	$1.42	N/A	N/A Q2 2021
Biotechnology Oyster Point Pharma, Inc. Portfolio share: 0.07% Portfolio value: 48K Avg. open price: N/A Current price: $11.12 P/L: N/A Sold -37.04% shares Q2 2022	share	0.07%	48K	N/A	$11.12	N/A	Sold -37.04% shares Q2 2022
Biotechnology TRACON Pharmaceuticals, Inc. Portfolio share: 0.07% Portfolio value: 48K Avg. open price: N/A Current price: $1.5 P/L: N/A N/A Q2 2021	share	0.07%	48K	N/A	$1.5	N/A	N/A Q2 2021
Software—Application Yalla Group Limited Portfolio share: 0.06% Portfolio value: 44K Avg. open price: N/A Current price: $3.73 P/L: N/A N/A Q2 2021	share	0.06%	44K	N/A	$3.73	N/A	N/A Q2 2021
Biotechnology Sio Gene Therapies Inc. Portfolio share: 0.06% Portfolio value: 41K Avg. open price: N/A Current price: $0.32 P/L: N/A Sold -20.81% shares Q1 2022	share	0.06%	41K	N/A	$0.32	N/A	Sold -20.81% shares Q1 2022
Biotechnology SQZ Biotechnologies Company Portfolio share: 0.05% Portfolio value: 36K Avg. open price: $14.45 Current price: $1.55 P/L: -89.27% Sold -27.27% shares Q4 2021	share	0.05%	36K	$14.45	$1.55	-89.27%	Sold -27.27% shares Q4 2021
Biotechnology PDS Biotechnology Corporation Portfolio share: 0.05% Portfolio value: 36K Avg. open price: $12.55 Current price: $9.78 P/L: -22.07% Sold -80.00% shares Q2 2022	share	0.05%	36K	$12.55	$9.78	-22.07%	Sold -80.00% shares Q2 2022
Biotechnology Cyteir Therapeutics, Inc. Portfolio share: 0.04% Portfolio value: 29K Avg. open price: $21.4 Current price: $1.42 P/L: -93.36% Bought +16566.67% shares Q3 2021	share	0.04%	29K	$21.4	$1.42	-93.36%	Bought +16566.67% shares Q3 2021
Drug Manufacturers—Specialty & Generic CBDMD INC Portfolio share: 0.04% Portfolio value: 28K Avg. open price: $2.08 Current price: $0.32 P/L: -84.43% Bought +21.95% shares Q4 2021	share	0.04%	28K	$2.08	$0.32	-84.43%	Bought +21.95% shares Q4 2021
Biotechnology BioLineRx Ltd. Portfolio share: 0.03% Portfolio value: 25K Avg. open price: N/A Current price: $0.72 P/L: N/A N/A Q2 2021	share	0.03%	25K	N/A	$0.72	N/A	N/A Q2 2021
Biotechnology Instil Bio, Inc. Portfolio share: 0.03% Portfolio value: 24K Avg. open price: N/A Current price: $1.25 P/L: N/A Sold -50.00% shares Q2 2022	share	0.03%	24K	N/A	$1.25	N/A	Sold -50.00% shares Q2 2022
Biotechnology Syros Pharmaceuticals, Inc. Portfolio share: 0.03% Portfolio value: 23K Avg. open price: $3.3 Current price: $4 P/L: +21.21% N/A Q3 2022	share	0.03%	23K	$3.3	$4	+21.21%	N/A Q3 2022
Biotechnology Aravive, Inc. Portfolio share: 0.02% Portfolio value: 15K Avg. open price: $2.19 Current price: $1.46 P/L: -33.22% Bought +7.30% shares Q2 2022	share	0.02%	15K	$2.19	$1.46	-33.22%	Bought +7.30% shares Q2 2022
Medical Care Facilities AirSculpt Technologies, Inc. Portfolio share: 0.01% Portfolio value: 10K Avg. open price: N/A Current price: $3.67 P/L: N/A Sold -98.52% shares Q2 2022	share	0.01%	10K	N/A	$3.67	N/A	Sold -98.52% shares Q2 2022
Biotechnology TransCode Therapeutics, Inc. Portfolio share: 0.01% Portfolio value: 7K Avg. open price: N/A Current price: $0.43 P/L: N/A Sold -87.00% shares Q2 2022	share	0.01%	7K	N/A	$0.43	N/A	Sold -87.00% shares Q2 2022
Diagnostics & Research Genetron Holdings Limited Portfolio share: 0.01% Portfolio value: 6K Avg. open price: N/A Current price: $1.04 P/L: N/A N/A Q2 2021	share	0.01%	6K	N/A	$1.04	N/A	N/A Q2 2021
Biotechnology Atara Biotherapeutics, Inc. Portfolio share: 0.00% Portfolio value: 3K Avg. open price: N/A Current price: $4.76 P/L: N/A Sold -90.22% shares Q3 2022	share	0.00%	3K	N/A	$4.76	N/A	Sold -90.22% shares Q3 2022
Gambling Lottery.com Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.29 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.29	N/A	Sold -100.00% shares Q3 2022
Biotechnology Immatics N.V. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $11.26 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$11.26	N/A	Sold -100.00% shares Q3 2022
Gambling Lottery.com Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.02 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.02	N/A	Sold -100.00% shares Q3 2022
Biotechnology Maravai LifeSciences Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $13.91 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$13.91	N/A	Sold -100.00% shares Q3 2022
Specialty Chemicals Livent Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $28 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$28	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Lantheus Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $61.27 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$61.27	N/A	Sold -100.00% shares Q3 2022
Software—Infrastructure Mogo Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.85 Current price: $0.61 P/L: -92.20% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.85	$0.61	-92.20%	Sold -100.00% shares Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $111.44 Current price: $41.84 P/L: -62.46% Sold -100.00% shares Q3 2022	share	0.00%	0	$111.44	$41.84	-62.46%	Sold -100.00% shares Q3 2022
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $20.99 Current price: $17.98 P/L: -14.34% Sold -100.00% shares Q3 2022	share	0.00%	0	$20.99	$17.98	-14.34%	Sold -100.00% shares Q3 2022
Medical Devices Helius Medical Technologies, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $16.99 Current price: $0.29 P/L: -98.29% Sold -100.00% shares Q3 2022	share	0.00%	0	$16.99	$0.29	-98.29%	Sold -100.00% shares Q3 2022
Biotechnology Rhythm Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $28.32 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$28.32	N/A	Sold -100.00% shares Q3 2022
Biotechnology Cellectar Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.87 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.87	N/A	Sold -100.00% shares Q3 2022
Agricultural Inputs CF Industries Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $104.39 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$104.39	N/A	Sold -100.00% shares Q3 2022
Biotechnology Syros Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $3.3 Current price: $4 P/L: +21.21% Sold -100.00% shares Q3 2022	share	0.00%	0	$3.3	$4	+21.21%	Sold -100.00% shares Q3 2022
Biotechnology Aurinia Pharmaceuticals Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $15.96 Current price: $5.1 P/L: -68.04% Sold -100.00% shares Q3 2022	share	0.00%	0	$15.96	$5.1	-68.04%	Sold -100.00% shares Q3 2022
Broadcasting Audacy, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.31 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.31	N/A	Sold -100.00% shares Q3 2022
Biotechnology Ampio Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.35 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.35	N/A	Sold -100.00% shares Q3 2022
Internet Retail Amazon.com, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $3,440.16 Current price: $94.13 P/L: -97.26% Sold -100.00% shares Q3 2022	share	0.00%	0	$3,440.16	$94.13	-97.26%	Sold -100.00% shares Q3 2022
Health Information Services Akerna Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.06 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.06	N/A	Sold -100.00% shares Q3 2022
Communication Equipment ADTRAN Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $18.45 Current price: $20.87 P/L: +13.12% Sold -100.00% shares Q3 2022	share	0.00%	0	$18.45	$20.87	+13.12%	Sold -100.00% shares Q3 2022

Showing TOP 91 ACT CAPITAL MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ACT CAPITAL MANAGEMENT, LLC?

The biggest position of the ACT CAPITAL MANAGEMENT, LLC is STAAR Surgical Company (STAA) with 21.69% portfolio share worth of 15.72M US dollars.

Top 5 ACT CAPITAL MANAGEMENT's holdings represent 49.02% of the portfolio:

STAAR Surgical Company (STAA) – 21.69%
Exxon Mobil Corporation (XOM) – 9.83%
Devon Energy Corporation (DVN) – 6.85%
Krystal Biotech, Inc. (KRYS) – 5.61%
Arrowhead Pharmaceuticals, Inc. (ARWR) – 5.04%

Who is the portfolio manager of ACT CAPITAL MANAGEMENT, LLC?

The portfolio manager of the ACT CAPITAL MANAGEMENT, LLC is .

What is the total asset value of the ACT CAPITAL MANAGEMENT, LLC portfolio?

ACT CAPITAL MANAGEMENT, LLC total asset value (portfolio value) is 72.46M US dollars.

Who is ?

is the portfolio manager of the ACT CAPITAL MANAGEMENT, LLC.

What is (ACT CAPITAL MANAGEMENT, LLC) fund performance?

ACT CAPITAL MANAGEMENT's quarterly performance is +0.41%, annualy -62.35%.

What is the ACT CAPITAL MANAGEMENT, LLC CIK?

ACT CAPITAL MANAGEMENT's Central Index Key is 0001442273 .